Form 4: LivaNova Director Todd Schermerhorn Reports Routine Stock Transactions and New RSU Grant

LivaNova PLC Director Todd C. Schermerhorn reported the vesting of restricted stock units, acquisition of ordinary shares, and a new RSU grant, alongside shares withheld for tax liabilities.

Summary

• Todd C. Schermerhorn, a Director of LivaNova PLC (LIVN), reported transactions on June 15, 2025, related to his beneficial ownership.
• He acquired 3,416 ordinary shares of LivaNova PLC at a price of $0, resulting from the vesting and settlement of previously granted restricted stock units (RSUs) under the Company's 2015 Incentive Award Plan.
• Concurrently, 410 ordinary shares were disposed of at a price of $45.76 per share to satisfy tax liabilities associated with the RSU vesting.
• Following these transactions, his direct beneficial ownership of ordinary shares decreased from 9,473 to 9,063.
• Additionally, Mr. Schermerhorn was granted 4,042 new Restricted Stock Units (RSUs) under the Company's 2025 Director Incentive Award Plan, which are scheduled to vest on June 15, 2026.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it reflects routine compensation and a new equity grant for a director, indicating continued alignment of interests, despite the necessary share disposal for tax purposes.

Positives

• Director Todd C. Schermerhorn received 3,416 ordinary shares from the vesting of previously granted Restricted Stock Units, indicating a successful realization of prior compensation.
• A new grant of 4,042 Restricted Stock Units was awarded to the Director, aligning his future incentives with the company's performance and demonstrating continued commitment to his role.

Negatives

• 410 ordinary shares were disposed of at $45.76 per share to cover tax liabilities, which is a common occurrence with RSU vesting but reduces the net shares retained by the director.

Future Outlook

The newly granted 4,042 Restricted Stock Units are scheduled to vest on June 15, 2026, subject to continued service, indicating future equity compensation for the director.

Industry Context

This Form 4 filing is a routine disclosure of insider stock transactions, common across all publicly traded companies, particularly for executive and director compensation involving equity awards like Restricted Stock Units. It reflects standard compensation practices within the medical technology industry.

Corporate Governance

Stakeholder Impact

• Shareholders: The report details changes in a director's direct shareholdings, providing transparency on insider activity. The new RSU grant aligns the director's future incentives with shareholder value.
• Employees: While not directly impacting general employees, the use of incentive award plans for directors reflects a broader compensation philosophy that may extend to other levels of the organization.

Next Steps

• The 4,042 Restricted Stock Units granted on June 15, 2025, are expected to vest on June 15, 2026, contingent on continued service.

Key Dates

Keywords

LivaNova PLC, LIVN, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Director Compensation, Equity Compensation, Share Acquisition, Tax Withholding